Staging of tumors is very important in treatment and surgical decision making, as well as in predicting disease recurrence and prognosis. This review focuses on the different available classifications of juvenile nasopharyngeal angiofibroma (JNA) and their impact on the evaluation, management, and prognosis of JNA. The literature was reviewed, and publications on JNA staging were examined. Our MEDLINE search of the entire English-language literature found no review article on the current available staging systems for JNA. In this article, we review the common JNA classification systems that have been published, and we discuss some of their advantages and disadvantages. The most commonly used staging systems for JNA are the Radkowski and the Andrews-Fisch staging systems. However, some newer staging systems that are based on advances in technology and surgical approachesthe Onerci, INCan, and UPMC systems-have shown promising utility, and they will probably gain popularity in the future.
Introduction
Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign nasopharyngeal tumor that accounts for 0.05 to 0.5% of all head and neck tumors. 1 It exclusively affects adolescent boys. 1 It was first described in 1906 by Chauveau, who gave it its name. 2 However, the oldest recorded surgical procedure for JNA is attributed to Hippocrates, who performed a longitudinal splitting of the nasal ridge to remove a JNA. 3 Histologically, JNAs are unencapsulated tumors consisting of abundant vascular channels that lack the normal muscular layer in the channel wall, which explains their tendency toward spontaneous bleeding.
The vascular channels are surrounded by a network of fibrocollagenous tissue. 4 Although they are histologically benign, JNAs are highly vascular, locally aggressive, and destructive in nature. They tend to expand into the nose, paranasal sinuses, vidian canal, and pterygopalatine fossa. 5 From there, they can invade the infratemporal fossa through the pterygomaxillary fissure, or they can extend into the orbit through the inferior orbital fissure or into the middle cranial fossa, either directly or through the foramen lacerum, foramen rotundum, foramen ovale (via extension beyond the sphenoid sinus and vidian canal), or superior orbital fissure. Erosion through the posterior wall of the sphenoid sinus can result in intracranial extension. 6 Etiology. The etiology of JNA is still unclear. [7] [8] [9] Osborn in 1959 proposed that the tumor could be either a hamartoma or a growth of residual fetal erectile tissues under hormonal stimulation. 9 Girgis and Fahmy considered the tumor as a paraganglioma based on the histologic appearance of undifferentiated epithelioid cells at the margins of the JNA. 10 Schick et al suggested that JNA represents the growth of a residual vascular plexus from the involution of the first branchial artery. 11 This artery communicates with the internal carotid artery and the maxillary artery temporarily during fetal life, and its persistence may lead to the development of JNA secondary to growth stimulation at the time of adolescence. This could explain the occasional vascular contribution from the internal carotid artery. Another theory is that JNA develops from a steroid-stimulated hamartomatous turbinate tissue, which would explain the natural involution of JNA after puberty. 10 To date, the most accepted theory of JNA genesis is that it arises as a result of repeated episodes of microhemorrhages and repair by fibrous tissue formation in the area of the sphenopalatine foramen, which is rich in vascular erectile tissues that dilate in response to the increase in sexual hormone production during adolescence. 12 This process is believed to lead to the formation Juvenile nasopharyngeal angiofibroma staging: an overview of JNA, especially if the capillaries were malformed.
The exact site of origin of JNA is also still unknown. However, there is a consensus that it originates in the superior margin of the sphenopalatine foramen at the point where the pterygoid process of the sphenoid bone meets the sphenoid process of the palatine bone and the horizontal ala of the vomer. 13 Diagnosis. Patients with JNA usually present with unilateral nasal obstruction, recurrent epistaxis, and a nasopharyngeal mass. As the disease advances, patients may present with facial swelling, cranial neuropathy, and proptosis. 1 Biopsy is contraindicated because of the risk of intractable bleeding. The diagnosis is made by considering elements of the clinical presentation with radiologic findings on contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI), and/or angiography.
Treatment. There is general agreement that surgery is the best modality of treatment available for JNA. 14 Based on the fact that JNA is a highly vascular tumor, preoperative angiography and embolization of the feeding vessels from the external carotid artery are highly recommended by many surgeons as a means of reducing the risk of extensive intraoperative bleeding. Different surgical approaches have been described in the literature; they include transpalatal, lateral rhinotomy, transantral, midface degloving, infratemporal fossa, craniotomy, transnasal microscopic, and transnasal endoscopic approaches. 13 Other described techniques for resection of JNAs include the use of the KTP laser and ultrasonically activated scalpel. 15 Other treatment modalities have been used, mostly for extensive disease with intracranial invasion, for residual or recurrent tumors at surgically inaccessible anatomic sites, and when a high risk of major complications is anticipated. These alternatives include radiotherapy, hormonal therapy, and embolization. More recently, gamma-knife radiosurgery has been used for the treatment of residual JNA after a conservative subtotal resection. 16 Even though transnasal endoscopic resection of JNAs has been used for more than a decade, clear indications for its use in different stages of JNA have yet to be established. Most surgeons consider the extent and growth pattern of the tumor to determine the feasibility of endoscopic removal. The endoscopic approach carries the advantages of minimal soft-tissue dissection, avoidance of facial incisions and facial bony disruption, the availability of a magnified multiangled view, and minimal morbidity with a short hospitalization time.
Nowadays, there is a consensus among most surgeons that tumors confined to the nasopharynx, pterygopalatine fossa, and paranasal sinuses can be successfully removed via a transnasal endoscopic approach. 17 However, the feasibility and efficiency of the endoscopic management of JNAs that invade the infratemporal fossa and/or the skull base is still problematic. 18, 19 Staging systems. Staging systems for any tumor are important because they usually standardize the guidelines for classification and management based on cumulative factors that influence the surgical decision, as well as the prognosis after surgery, including the risk of residual and recurrent disease. Staging systems also can serve to eliminate any confusion that might be engendered by different reports in the literature, and they allow for better inter-institutional data comparisons.
Many systems have been proposed to classify the stages of JNA. Factors that influence surgical decision making in JNA include the extent and size of a tumor, the technical difficulties encountered in surgery, and the common sites of residual and recurrent disease. 20 In this article, we review the classification systems for JNA, and we discuss their impact on evaluation, management, and prognosis, as well as some of the advantages and disadvantages of the different systems.
Literature review
We conducted a structured review of the PubMed, Embase, and Cochrane Collaboration databases (the Cochrane Central Register of Controlled Trials and the Cochrane Database of Systematic Reviews) using the following MeSH terms: juvenile nasopharyngeal angiofibroma, nasopharyngeal tumor, nasopharyngeal disease, juvenile angiofibroma, angiofibroma staging, tumor classification, and tumor staging. We found no randomized controlled trials or systematic reviews in the entire English-language literature regarding the use of different staging systems for JNA and their influence in management decisions and predictions of residual and recurrent disease. Therefore, we conducted our own review of published staging systems. The details of some of these systems are shown in table 1. A summary of reports on the treatment of JNA is shown in table 2.
Sessions system. Introduced in 1981, the Sessions classification system is regarded as the first standardized JNA staging system (table 1). 21 Sessions and colleagues proposed this radiologic staging system with the goal of eliminating confusion among different institutions with regard to surgical approaches, morbidity, and cure rates. They used CT scans to define the anatomic location of the disease, and they used nasopharyngeal carcinoma as a staging model. They believed that it is tumor extension rather than tumor size that determines the stage and the surgical approach to tumor clearance. However, Sessions et al failed to incorporate surgical challenges, treatment outcomes, and sites of residual or recurrent disease into their classification system. Furthermore, at that time, "intracranial extension" was a general term that did not specify whether the dura had been penetrated. In our opinion, this is of great importance in surgical planning and prognosis, but the major pitfall of the Sessions system is that it is based on the staging of nasopharyngeal carcinoma. Basing the staging system of a benign process on that of a malignant process is likely to result in generally inaccurate findings, since the pathophysiology, nature, and behavior of these two processes is completely different.
Chandler system. The system devised by Chandler et al in 1984 was based on the clinical evaluation of tumor extension and size combined with radiologic findings on CT and/or MRI (table 1). 22 Their system integrated known tumor extension and rational planning with the therapeutic approaches available at that time.
This system has been adopted by some surgeons and found to be useful in making decisions about the surgical approach and management of different JNA patients. However, Chandler et al staged nasal cavity involvement higher than nasopharyngeal involvement, suggesting that the former requires different and more extensive surgery, which is not the case. In addition, they failed to consider the complexity of intracranial extension, and thus their system achieved less popularity than did some of the other systems. Ultimately, their system is unreliable because it was based on the American Joint Committee on Cancer system; as noted, angiofibroma is a benign lesion that follows a different course from malignant lesions.
Antonelli system. An interesting classification system was introduced by Antonelli et al in 1987 (table 1) . 23 They based their system on their experience in managing 19 cases of JNA. Their system was based entirely on clinicoradiologic data on tumor size and extension. However, this system did not gain popularity, probably because it did not correlate well with surgical approaches and outcomes. For example, stage III in this system included maxillary and ethmoid sinus extension along with infratemporal fossa involvement, even though infratemporal involvement requires more extensive surgery than does extension into the maxillary or ethmoid sinuses. in skull base surgery, Fisch introduced a staging system for JNA, which he, Andrews, and others modified in 1989; the modification is called the Andrews-Fisch system (table 1). 24 This system has become one of the most popular in use today. In fact, most surgeons worldwide consider it to be the standard.
Andrews-Fisch system. Based on his wide experience
In their report, Andrews, Fisch, and colleagues described in detail the growth pattern of JNA as it originates in the superior margin of the sphenopalatine foramen at the junction of the sphenoid process of the palatine bone and the pterygoid process of the sphenoid bone. 24 From there, the tumor grows into the nasopharyngeal and nasal spaces anteriorly and posteriorly before it erodes the bones of the maxillary, ethmoid, and sphenoid sinuses. It can also spread to the pterygopalatine fossa, and from there it can erode the pterygoid plates and spread into the infratemporal fossa or through the inferior orbital fissure into the orbit. From the base of the pterygoid plates, the tumor can expand through three foramina (lacerum, rotundum, and ovale) into the middle cranial fossa, where it can further invade the parasellar area without intradural invasion. In very rare and very advanced stages, the tumor can erode the posterior wall of the sphenoid sinus and infiltrate the pituitary fossa, optic chiasm, and/or the cavernous sinus.
This analysis of growth characteristics and the complexity of tumor extensions, especially at the skull base, made this classification system well recognized internationally as the first comprehensive, practical, and applicable guide to the surgical approach and prediction of outcome in the management of JNA.
For example, this system classifies erosion into the skull base without intradural extension as stage III, while intradural growth is classified as stage IV. This distinction is very well explained by the fact that extradural invasion of the skull base is operable and can be extirpated completely without major complications, while intradural invasion is associated with a high risk of major complications and, if it is extensive, should be treated with tumor debulking and postoperative radiotherapy.
The Andrews-Fisch system was designed during a time when the only surgical approaches available for tumors at this region were open procedures. Therefore, its major drawback in terms of current application in our opinion is that it does not take into account recent advances in both radiologic imaging and surgical techniques. As a result, it is difficult to predict cure rates, risks of complications, and sites of residual and recurrent disease with the Andrews-Fisch system.
Mishra system. That same year, Mishra et al proposed their system, but it did not become widely accepted. 25 Their system was based on their experience with 100 cases of JNA. They noticed that the growth pattern of JNA differs according to the patient's age at presentation in that it is more extensive in adolescents than in patients younger than 10 years. They also classified tumor extension chronologically as primary, secondary, and tertiary. They proposed that (1) primary extensions grow in an anterior, posterior, or medial direction, (2) secondary extensions start growing laterally or to the contralateral nostril, and (3) tertiary extensions invade the cheek, orbit, infratemporal fossa, and skull base.
Mishra et al based their system on their earlier analyses of patterns of growth and extension and the available surgical approaches and modalities. However, despite the fact that they gave great consideration to the different categories of extension and subclassified skull base extension according to the presence or absence of dural involvement, they did not give due consideration to all of the surgical options that were available at the time.
Another shortcoming of the Mishra system is that only 25% of the cases the authors reviewed had been well evaluated preoperatively by CT. Finally, they reported a noticeably high surgical failure rate (27%). All of these issues put the validity and applicability of the Mishra system into question. Bagatella-Mazzoni system. In 1995, Bagatella and Mazzoni suggested a modification of the original Fisch staging system (table 1) . 26 The new system took into account the progressive degrees of tumor extension and the surgical difficulties encountered in attacking them. The authors based their classification on 34 consecutively presenting cases of JNA that were all managed with a similar microscopic transmaxillary surgical approach. In our opinion, the Bagatella-Mazzoni system was hard to adopt because it failed to guide surgical decision making or to correlate with the prognosis.
Radkowski system. In 1996, Radkowski et al suggested some modifications to the Sessions system based on their experience with 23 cases (table 1). 27 They contended that preoperative tumor stage is the primary factor affecting tumor recurrence. The Radkowski system combined the advantages of some of the other systems and correlated each stage with the best surgical approach that would minimize the risk of residual or recurrent tumor. Their system has become one of the most widely used today.
One modification of the Sessions system involved stage II; Radkowski et al added tumor extension posterior to the pterygoid plates to stage IIC. They also modified stage III by subdividing it into substages IIIA and IIIB. Stage IIIA was defined as minimal skull base involvement, including the middle cranial fossa and/or base of the pterygoid plates; stage IIIB was defined as extensive intracranial involvement with or without invasion into the cavernous sinus. Based on their new system, Radkowski et al graded 9 of their 23 cases higher than they would have been graded with the Sessions system; 4 cases were upgraded to stage IIC and 5 to stage IIIB. 23 The popularity of the Radkowski system notwithstanding, the analysis by Radkowski et al showed that there was some confusion about the Sessions system; Radkowski et al thought that Sessions had classified minimal intracranial extension as stage IIC when in fact Sessions listed intracranial extension in general as stage III. Moreover, the upgrading of some cases did not change the way they were managed, nor did it have an effect on recurrence; recurrences after primary surgery were seen in 5 of the 23 cases (22%), 3 of which had been upgraded.
Onerci system. By 2006, advances in endoscopic and microscopic surgery and the evolution of new techniques in preoperative evaluation and embolization prompted a desire for a new classification system based on the sites of residual and recurrent disease. To that end, Onerci et al suggested a modification of existing staging systems based on their retrospective analysis of 36 patients they treated (table 1) . 28 Based on disease extent, their system took into account the new surgical approaches that had evolved and the surgical difficulties that had been encountered, as well as the sites of residual disease. Their aim was to achieve a better evaluation of the tumor and a reduction in the risk of residual and recurrent disease. In the Onerci system, involvement of the ethmoid and sphenoid sinuses was considered stage I disease because in these cases, the tumor can be completely removed via an endoscopic endonasal approach without additional surgical challenges.
Maxillary sinus extension and total involvement of the pterygopalatine fossa were both classified as stage II, since both situations indicate the presence of a large tumor that will require some modifications of the surgical approach and technique. Minimal involvement of the infratemporal fossa, defined as no extension beyond the lateral border of the posterior maxillary sinus wall, was also classified as stage II disease, since the authors believed that such an extension could be removed endoscopically.
Infratemporal fossa involvement beyond the lateral border of the posterior maxillary sinus wall was classified as stage III disease, since it necessitates an external surgical approach for complete tumor clearance.
Despite the fact that some reports in the literature had revealed that the most common site of disease recurrence was the base of the pterygoid plates (75 to 93% of cases), 28 Onerci et al were the first to address this issue. They believed that such involvement was not only associated with a high rate of recurrence, but it also might indicate the presence of middle cranial fossa extension because it is considered to be the most likely route of intracranial involvement. Therefore, extension into the cancellous bone of the pterygoid plates and involvement of the pterygoid muscles were classified as stage III disease.
Intracranial extension was classified according to the site of involvement. Anterior cranial fossa extension was classified as stage II disease since it is approachable endoscopically, while middle cranial fossa extension was classified as stage IV disease because it requires an external approach for its clearance. According to Onerci et al, all stage IV tumors are extensive and should be managed via a combined endoscopic and external approach, although complete clearance occasionally may not be possible. The Onerci staging system is relatively new, and it has been tested in only one study of 46 cases of JNA reported by Nicolai et al in 2010 (table 2) . 29 However, these tumors had been resected entirely through an endoscopic approach, despite the fact that 26 of these cases were Onerci stage III tumors. Although we believe that the Onerci staging system is quite comprehensive and based on long experience with the management of JNA via both open and endoscopic approaches, the possibility that it would fail to guide the surgeon to the best resection modality is a significant drawback. Further reports are needed to evaluate the validity of the Onerci staging system.
Tyagi system. Later in 2006, Tyagi et al proposed some modifications to stages II, III, and IV of the Andrews-Fisch system. 30 They based their classification of intracranial extradural extension on the size of the tumor and the surgical approach necessary for its excision. Small extradural extensions were classified as stage IIIB, and the recommended surgical approach was a combined transpalatal and transmaxillary procedure. Large extradural extension was classified stage IVA, and frontotemporal craniotomy was the recommended approach.
In their report of 95 cases of JNA ranging between stage II and IV, they indicated that most cases were resected via an open approach (table 2) . 30 However, their modification has not been advocated by other authors who subsequently reported their own series. We believe that their modification did not address advancements in endoscopic sinus and skull base surgery.
INCan system. In 2008, Carrillo et al at the Instituto Nacional de Cancerologia (INCan) in Mexico City introduced a promising new staging system that was based on correlating tumor size, tumor location, the best surgical approach, and the recurrence rate (table 1). 31 They had retrospectively reviewed 54 cases of JNA and compared recurrence rates and disease-free survival (DFS) between the Andrews-Fisch and Radkowski sys-tems (table 2) . With the Radkowski system, they found that DFS for stage IIIB patients was better than that for stage IIIA patients. According to the Andrews-Fisch system, patients with stage IIIB disease had a shorter DFS than did those with stage IVA and IVB disease.
Carrillo et al also found that tumor size was a significant factor in recurrence and DFS in the early stages (stage I and II). Other factors that contributed to high recurrence rates and shorter DFS were extension of the tumor into the pterygomaxillary fissure, intracranial invasion, skull base invasion, and infratemporal fossa invasion. Based on these findings, the authors subclassified infratemporal fossa invasion as anterior and posterior in relation to the pterygoid plates. They also classified skull base invasion according to the degree of dural penetration.
According to the INCan system, stage I and stage IIA disease can be managed exclusively via an endoscopic approach, stage IIB and stage III via a combined endoscopic and open approach (preferably facial degloving), and stage IV via a combined anterolateral or lateral skull base approach. Carrillo et al concluded that the INCan system has a better impact on the prediction of recurrence and DFS for patients with advanced disease. As such, it serves as a good guide to the best surgical approach in each stage of disease. However, since this classification is relatively new, its applicability and success have yet to be determined.
UPMC system. Finally, in 2010, Snyderman and colleagues at the University of Pittsburgh Medical Center (UPMC) introduced the most recent endoscopic staging system for JNA (table 1). 32 They took into consideration the current advancements in endonasal surgical approaches, the routes for intracranial extension of the tumor, and the extent of vascular supply from the internal carotid artery (ICA); they believed that the size of the tumor and its extension into the sinuses are less predictive of outcome after endonasal resection. In their series, 74% of cases involved skull base erosion, and 51% involved residual vascularity from the ICA after embolization of the external carotid artery tributaries (table 2) . They considered these to be the most important predictive factors for prognosis in terms of blood loss, the number of operations required to resect the tumor completely, and tumor recurrence. As such, the staging system they proposed classified the presence of residual vascularity from the ICA as stage IV, while intracranial extension was classified as stage V.
The UPMC system is very comprehensive, and it takes into consideration the nature of the tumor and current surgical approaches. In addition, it correlates well with prognosis. Finally, it gives surgeons the choice to take the surgical approach of their preference. However, surgeons can stage JNA with the UPMC system only after embolization of the tumor. In other words, if no embolization is performed before surgery, the UMPC staging system is not applicable. In addition, this staging system is not a guide to determining which approach should be used for each JNA stage. Finally, because it is a new system, it needs to be adopted by more surgeons before its validity can be ascertained.
Conclusion
When looking at some of the series of JNA cases that have been published in the literature over the past 15 years, it is clear that the Radkowski system and either the original Fisch system or the Andrews-Fisch system were the most frequently used by surgeons (table 2) . 4, 5, 7, 13, 14, 17, 19, 20, It appears that surgeons have found that these systems correlate accurately and significantly with their decisions on surgical approaches to JNA with different degrees of extension and that they are good indicators of disease recurrence and prognosis. In addition, it is important to consider the Onerci, INCan, and UPMC systems, which seem to correlate better with current advances in diagnostic imaging and surgical techniques. However, since these three systems are relatively new, more experience with them is encouraged before we advocate any one of them as the new standard upon which to stage JNA.
In this review, we have highlighted the existing controversies regarding the staging of JNA. Nowadays, with the significant advances in our understanding of transnasal endoscopic approaches, instrumentation, and imaging technology-such as intraoperative MRI and image-guided navigation systems-there has been a noticeable change in the expected rates of residual and recurrent disease, as well as the overall prognosis for patients with JNA.
There has long been a substantial need for a universal standardized JNA staging system that takes into consideration all the factors that play a role in JNA. In our opinion, only one system-the UPMC system-meets this need. However, since this system is still new and has not been clinically applied by surgeons other than Snyderman et al, 32 there is a need for an integrated multidisciplinary effort by experienced surgeons to use the UPMC system and to share their experiences with it in terms of its credibility and feasibility as a balanced, informative, and guiding staging system. Once that happens, perhaps it can be universally adopted as the ideal standardized staging system for JNA.
